Hepatitis E virus infection epidemiology in allogeneic hematopoietic cell transplant recipients

Resource type
Journal Article
Authors/contributors
Title
Hepatitis E virus infection epidemiology in allogeneic hematopoietic cell transplant recipients
Abstract
Among 292 allogeneic hematopoietic cell transplant recipients (allo-HCTr, 2018-2022), 64 (21.9%) tested positive for anti-HEV-IgG and among 208 allo-HCTr tested by plasma/serum-HEV-PCR (2012-2022) 3 (1.4%) primary HEV infections were diagnosed; in one patient plasma HEV-PCR relapsed positive for 100 days. HEV infection remains rare albeit associated with persistent viral replication.
Publication
Open Forum Infectious Diseases
Date
2023-11-24
Pages
ofad595
Journal Abbr
Open Forum Infectious Diseases
Accessed
12/3/23, 10:36 AM
ISSN
2328-8957
Library Catalog
Silverchair
Citation
Courjon, J., Portillo, V., Yerly, S., Vetter, P., Schibler, M., Mappoura, M., Morin, S., Giannotti, F., Mamez, A.-C., van Delden, C., Kaiser, L., Chalandon, Y., Masouridi-Levrat, S., & Neofytos, D. (2023). Hepatitis E virus infection epidemiology in allogeneic hematopoietic cell transplant recipients. Open Forum Infectious Diseases, ofad595. https://doi.org/10.1093/ofid/ofad595
HEME-ONC AND CELLULAR THERAPIES
Link to this record